From pharmaceutical procurement managers in Mumbai and API manufacturers in Ahmedabad to generic drug companies operating out of Hyderabad India's pharma sector is actively rethinking how it scales production. With the global "China Plus One" strategy reshaping supply chains and the U.S. BIOSECURE Act pushing multinationals to diversify sourcing, CDMO manufacturing partners based in India have never been more strategically valuable to pharma R&D heads, formulation specialists, and API producers across Maharashtra, Gujarat, and Telangana. 

Headquartered at Navi Mumbai's MIDC industrial zone, is a fully integrated contract research and manufacturing organisation built precisely for this moment. Established in 1992, SARA Research & Development Centre (SRDC) brings over 30 years of expertise in custom synthesis, organic process research, and specialty chemical manufacturing, serving pharmaceutical companies, generic drug manufacturers, and API producers across Maharashtra, Gujarat, South India, and Delhi-NCR. 

SARA Research & Development Centre (SRDC) 's multi-floor MIDC facility is equipped with SS, GLR, Nickel, MS, and FRP reactors, supported by a real-time data acquisition system ensuring process transparency, quality consistency, and regulatory accountability at every stage. With small molecules commanding a 67.2% share of India's CDMO services market, SARA Research & Development Centre (SRDC) 's core chemistry capabilities are a direct answer to the sector's most pressing outsourcing needs. 

India's pharma window is wide open claim your outsourcing advantage before your competitors do. 

Explore SARA Research & Development Centre (SRDC) 's CRAMS capabilities now. 

Visit our page:  https://sararesearch.com/crams 

Address: W‐250, M.I.D.C, TTC, Rabale, Navi Mumbai ‐ 400 701, Maharashtra, India 

Contact us: https://sararesearch.com/contact-us 

Visit our website:  https://sararesearch.com/